Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,275,342 papers from all fields of science
Search
Sign In
Create Free Account
Inner Diameter
Known as:
Inner/Lumen Diameter
, Lumen Diameter
The length of a straight line passing through the center of the inner open space or cavity of a circular or spheroid object (such as a tubular organ…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)
J. Schofer
,
M. Schlüter
,
+4 authors
G. Breithardt
The Lancet
2003
Corpus ID: 24614874
Highly Cited
2003
Highly Cited
2003
Left main coronary artery fistula exiting into the right atrium
B. Heublein
,
R. Rohde
,
V. Kaese
,
M. Niemeyer
,
W. Hartung
,
A. Haverich
Heart
2003
Corpus ID: 12864603
Objectives: To develop and test a new concept of the degradation kinetics of newly developed coronary stents consisting of…
Expand
Highly Cited
2001
Highly Cited
2001
Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials
D. Cutlip
,
D. Baim
,
+7 authors
R. Kuntz
Circulation
2001
Corpus ID: 35655130
BackgroundThere are limited studies of stent thrombosis in the modern era of second-generation stents, high-pressure deployment…
Expand
Highly Cited
2001
Highly Cited
2001
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
Diabetes Atherosclerosis Intervention Study Investigators
The Lancet
2001
Corpus ID: 22929741
Highly Cited
2001
Highly Cited
2001
Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents: One-Year Angiographic and Intravascular Ultrasound Follow-Up
Sousa
,
R. Falotico
,
+11 authors
B. Rensing
Circulation
2001
Corpus ID: 9804747
Background—We have previously reported a virtual absence of neointimal hyperplasia 4 months after implantation of sirolimus…
Expand
Highly Cited
2000
Highly Cited
2000
Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.
E. Schiffrin
,
J. Park
,
H. Intengan
,
R. Touyz
Circulation
2000
Corpus ID: 5703283
BACKGROUND Structural and functional alterations of the vasculature may contribute to complications of hypertension. Because…
Expand
Highly Cited
1997
Highly Cited
1997
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
Post Coronary Artery Bypass Graft Trial Investigators
New England Journal of Medicine
1997
Corpus ID: 39661035
BACKGROUND Obstructive changes often occur in aortocoronary saphenous-vein bypass grafts because of atherosclerosis and…
Expand
Highly Cited
1994
Highly Cited
1994
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
M-heart investigators
The Lancet
1994
Corpus ID: 9273572
Highly Cited
1992
Highly Cited
1992
Lumen Diameter of Normal Human Coronary Arteries: Influence of Age, Sex, Anatomic Variation, and Left Ventricular Hypertrophy or Dilation
J T Dodge
,
B. G. Brown
,
E. Bolson
,
H. Dodge
Circulation
1992
Corpus ID: 10254342
BackgroundPrecise knowledge of the expected “normal” lumen diameter at a given coronary anatomic location is a first step toward…
Expand
Review
1990
Review
1990
Structure and function of small arteries.
M. Mulvany
,
C. Aalkjaer
Physiological Reviews
1990
Corpus ID: 9898044
The small arteries (prearteriolar vessels with lumen diameter less than approximately 500 microns) contribute importantly to and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE